Posters and Publications

Title

Ultrasensitive Structural Variant-based ctDNA detection of MRD in Colorectal Cancer

Date

January 10, 2026

Conference/Journal

ASCO GI 2026

Title

Prevalence and dynamics of circulating tumor DNA among patients with triple-negative breast cancer undergoing preoperative systemic therapy with or without immunotherapy

Date

December 10, 2025

Conference/Journal

SABCS 2025

Title

Neo-N: three-year event-free survival (EFS) and overall survival (OS) and ultrasensitive ctDNA and tumor infiltrating lymphocyte (TIL) dynamics in early triple-negative breast cancer (tnbc) treated with neoadjuvant carboplatin/paclitaxel and nivolumab

Date

December 9, 2025

Conference/Journal

SABCS 2025

Title

CATER-MRD: Capecitabine for Targeted Eradication of aRising ctDNA Molecular Residual Disease in ER+/HER2-negative Breast Cancer

Date

December 12, 2025

Conference/Journal

SABCS 2025

Title

CLAIRE: A Multicenter, Prospective Single-arm Phase II Study Evaluating Liquid Biopsy Guided Intensified Follow-up Surveillance in Patients with Intermediate to High-risk ER+/HER2-negative Early-stage Breast Cancer

Date

December 12, 2025

Conference/Journal

SABCS 2025

Title

Longitudinal ctDNA Tracking in Early and Recurrent Breast Cancer Using an Ultrasensitive Structural Variant-Based Assay: An Updated Analysis from the TRACER Study

Date

December 9, 2025

Conference/Journal

SABCS 2025

Title

NeoCircle: circulating tumor DNA (ctDNA) dynamics during neoadjuvant chemotherapy predicts survival in primary breast cancer

Date

June 2, 2025

Conference/Journal

ASCO 2025

Title

Detecting ctDNA using personalized structural variants to forecast recurrence in localized soft tissue sarcoma (STS)

Date

June 2, 2025

Conference/Journal

ASCO 2025

Title

Tumor-informed ctDNA as an early predictive marker for relapse in advanced epithelial ovarian cancer

Date

June 1, 2025

Conference/Journal

ASCO 2025

Title

Ultrasensitive Detection and Monitoring of Circulating Tumor DNA Using Structural Variants in Early-Stage Breast Cancer

Date

January 7, 2025

Conference/Journal

Clinical Cancer Research

Title

Tracking structural variants in ctDNA using a high-sensitivity assay predicts relapse in the post-neoadjuvant setting: the multicenter ALIENOR trial

Date

December 12, 2024

Conference/Journal

SABCS

Title

Somatic Structural Variation in Breast Cancer and its Application in Longitudinal Analysis of Circulating Tumor DNA in Early Breast Cancer

Date

December 12, 2024

Conference/Journal

SABCS

Title

Prevalence and dynamics of circulating tumor DNA among patients with triple-negative breast cancer undergoing preoperative systemic therapy with or without immunotherapy

Date

December 10, 2025

Conference/Journal

SABCS 2025

Title

Neo-N: three-year event-free survival (EFS) and overall survival (OS) and ultrasensitive ctDNA and tumor infiltrating lymphocyte (TIL) dynamics in early triple-negative breast cancer (tnbc) treated with neoadjuvant carboplatin/paclitaxel and nivolumab

Date

December 9, 2025

Conference/Journal

SABCS 2025

Title

CATER-MRD: Capecitabine for Targeted Eradication of aRising ctDNA Molecular Residual Disease in ER+/HER2-negative Breast Cancer

Date

December 12, 2025

Conference/Journal

SABCS 2025

Title

CLAIRE: A Multicenter, Prospective Single-arm Phase II Study Evaluating Liquid Biopsy Guided Intensified Follow-up Surveillance in Patients with Intermediate to High-risk ER+/HER2-negative Early-stage Breast Cancer

Date

December 12, 2025

Conference/Journal

SABCS 2025

Title

Longitudinal ctDNA Tracking in Early and Recurrent Breast Cancer Using an Ultrasensitive Structural Variant-Based Assay: An Updated Analysis from the TRACER Study

Date

December 9, 2025

Conference/Journal

SABCS 2025

Title

NeoCircle: circulating tumor DNA (ctDNA) dynamics during neoadjuvant chemotherapy predicts survival in primary breast cancer

Date

June 2, 2025

Conference/Journal

ASCO 2025

Title

Detecting ctDNA using personalized structural variants to forecast recurrence in localized soft tissue sarcoma (STS)

Date

June 2, 2025

Conference/Journal

ASCO 2025

Title

Tumor-informed ctDNA as an early predictive marker for relapse in advanced epithelial ovarian cancer

Date

June 1, 2025

Conference/Journal

ASCO 2025

Title

Ultrasensitive Detection and Monitoring of Circulating Tumor DNA Using Structural Variants in Early-Stage Breast Cancer

Date

January 7, 2025

Conference/Journal

Clinical Cancer Research

Title

Tracking structural variants in ctDNA using a high-sensitivity assay predicts relapse in the post-neoadjuvant setting: the multicenter ALIENOR trial

Date

December 12, 2024

Conference/Journal

SABCS

Title

Somatic Structural Variation in Breast Cancer and its Application in Longitudinal Analysis of Circulating Tumor DNA in Early Breast Cancer

Date

December 12, 2024

Conference/Journal

SABCS

Title

Tumor-informed ctDNA as an objective marker for postoperative residual disease in epithelial ovarian cancer

Date

June 3, 2024

Conference/Journal

ASCO 2024

Title

Monitoring ctDNA dynamics in early breast cancer using a novel ultra-sensitive tumor-informed structural variant approach combining whole-genome sequencing and multiplex dPCR

Date

June 2, 2024

Conference/Journal

ASCO 2024

Posters and Publications

Contact us

Follow us

Pathlight

About Us

Our Science

Pharma Partnering

News

Contact

Contact us

Follow us

Copyright © 2026 SAGA Diagnostics is a registered trademark and PATHLIGHT is a trademark of SAGA Diagnostics AB.

Copyright © 2025 SAGA Diagnostics is a registered trademark and PATHLIGHT is a trademark of SAGA Diagnostics AB.